Israel Ramirez-Sanchez

Dr. Israel Ramirez-Sanchez


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
GGGabriela Gutierrez-Salmean
Gabriela Gutierrez-Salmean
TCTheodore P. Ciaraldi
Theodore P. Ciaraldi
LNLeonardo Nogueira
Leonardo Nogueira
JBJonathan Barboza
Jonathan Barboza
Pam TaubPam Taub
Pam Taub
IRIsrael Ramirez-Sanchez
Israel Ramirez-Sanchez

2 August 2025 in Cells
Verified
Journal Article
Open access
PDF file
Angel Giovanni Arietta GarcíaAngel Giovanni Arietta García
Angel Giovanni Arietta García
Fernando CalzadaFernando Calzada
Fernando Calzada
AFAntonio Franco-Vadillo
Antonio Franco-Vadillo
IBIrais Barrientos-Buendía
Irais Barrientos-Buendía
FAFrancisco Alarcon Aguilar
Francisco Alarcon Aguilar
Rosa María Ordoñez-RazoRosa María Ordoñez-Razo
Rosa María Ordoñez-Razo
Breast cancer (BC) is the most common type of cancer in women worldwide. Hexokinase II (HKII) overexpression is associated with the proliferation and survival of tumor cells, as it inhibits apoptosis. Incomptine A (IA) is cytotoxic to breast cancer cells, likely due to a decrease in the expression of HKII. This study evaluated the antitumor activity of IA in an in vivo mouse model of BC. A model was generated from 4T1 cells and grouped tumor-bearing animals according to treatment: in IA or doxorubicin (DOXO), or untreated (UT). Comparing the body weight and tumor size between groups, tumors were analyzed using histopathological, Western blot, flow cytometry, and mitochondrial activity assays. Tumors IA-treated showed a reduction in size, weight, and number of tumor cells; the expression of HKII and Bcl-2 decreased, while that of Caspase-3 increased. IA treatment increased apoptosis and reduced mitochondrial activity in tumor cells. This data showed that IA has an impact on tumor cells by reducing tumor volume and size, increasing cell apoptosis, and decreasing mitochondrial activity, all of which could be attributed to reduced HKII expression. Therefore, IA may be a promising compound that requires further studies to elucidate its mechanism of action and analyze its possible future use in BC.